Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000055674 |
|---|---|
| Receipt number | R000063586 |
| Scientific Title | Observational study to investigate safety and effectiveness of lorlatinib as first line treatment for ALK-gene rearranged unresectable advanced/recurrent NSCLC patients in Japan clinical setting |
| Date of disclosure of the study information | 2024/10/01 |
| Last modified on | 2025/04/03 10:08:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2024/09/30 10:06:05 | ||
| 2 | Update | 2025/01/31 14:36:08 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2025/04/03 10:05:53 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Email1 |
|
| 4 | Update | 2025/04/03 10:08:52 | Email |